A. Fleckenstein

发表

Simultaneous quantification of nicotine and metabolites in rat brain by liquid chromatography-tandem mass spectrometry.

Eleanor I Miller, D. Wilkins, Paula L. Vieira-Brock, 2011, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

A single methamphetamine administration rapidly decreases vesicular dopamine uptake.

G. Hanson, J. Gibb, J. M. Brown, 2002, The Journal of pharmacology and experimental therapeutics.

Methamphetamine Increases Dopamine Transporter Higher Molecular Weight Complex Formation via a Dopamine- and Hyperthermia-Associated Mechanism

G. Hanson, A. Fleckenstein, E. Riddle, 2004, The Journal of Neuroscience.

Differential effects of methamphetamine on Na+/Cl−-dependent transporters

H. Haughey, G. Hanson, J. M. Brown, 2000, Brain Research.

Pathophysiology of Hemorrhagic Shock and the Protective Effects of Antioxidants

A. Fleckenstein, 1990 .

Prolactin regulation of tuberoinfundibular dopaminergic neurons: immunoneutralization studies

K. E. Moore, D. Lawson, K. Lookingland, 2000, Brain Research.

Regulation of the vesicular monoamine transporter-2: a novel mechanism for cocaine and other psychostimulants.

G. Hanson, A. Fleckenstein, J. M. Brown, 2001, The Journal of pharmacology and experimental therapeutics.

Differential effects of stimulants on monoaminergic transporters: pharmacological consequences and implications for neurotoxicity.

G. Hanson, J. Gibb, A. Fleckenstein, 2000, European journal of pharmacology.

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

G. Hanson, A. Fleckenstein, Christopher L. German, 2014, Life sciences.

Methamphetamine-induced rapid decrease in dopamine transporter function: role of dopamine and hyperthermia.

H. Haughey, R. Metzger, G. Hanson, 2000, The Journal of pharmacology and experimental therapeutics.

Cocaine-induced increases in vesicular dopamine uptake: role of dopamine receptors.

G. Hanson, A. Fleckenstein, J. M. Brown, 2001, The Journal of pharmacology and experimental therapeutics.

Role of monoamine transporters in mediating psychostimulant effects

G. Hanson, A. Fleckenstein, E. Riddle, 2005, The AAPS Journal.

Impact of psychostimulants on vesicular monoamine transporter function.

G. Hanson, A. Fleckenstein, 2003, European journal of pharmacology.

Methylphenidate‐Induced Alterations in Synaptic Vesicle Trafficking and Activity

G. Hanson, T. J. Volz, A. Fleckenstein, 2008, Annals of the New York Academy of Sciences.

Apomorphine increases vesicular monoamine transporter-2 function: implications for neurodegeneration.

G. Hanson, A. Fleckenstein, Jannine G Truong, 2004, European journal of pharmacology.

Differential Regional Effects of Methamphetamine on the Activities of Tryptophan and Tyrosine Hydroxylase

H. Haughey, G. Hanson, A. Fleckenstein, 1999, Journal of neurochemistry.

Methamphetamine rapidly decreases mouse vesicular dopamine uptake: role of hyperthermia and dopamine D2 receptors.

G. Hanson, A. Fleckenstein, E. Riddle, 2003, European journal of pharmacology.

Methamphetamine-Induced Rapid and Reversible Changes in Dopamine Transporter Function: An In Vitro Model

G. Hanson, A. Fleckenstein, E. Riddle, 2001, The Journal of Neuroscience.

Methamphetamine self‐administration acutely decreases monoaminergic transporter function

G. Hanson, K. Stout, D. Wilkins, 2012, Synapse.

Methamphetamine alters vesicular monoamine transporter‐2 function and potassium‐stimulated dopamine release

G. Hanson, K. Stout, Pei-Wen Chu, 2010, Journal of neurochemistry.

Methamphetamine Rapidly Decreases Vesicular Dopamine Uptake

G. Hanson, A. Fleckenstein, Jeffrey M. Brown, 2000, Journal of neurochemistry.

Rapid and reversible effects of methamphetamine on dopamine transporters.

R. Metzger, G. Hanson, J. Gibb, 1997, The Journal of pharmacology and experimental therapeutics.

Inhibitory effect of reserpine on dopamine transporter function.

G. Miller, R. Metzger, G. Hanson, 2002, European journal of pharmacology.

Oxygen radicals diminish dopamine transporter function in rat striatum.

R. Metzger, G. Hanson, J. Gibb, 1997, European journal of pharmacology.

The role of the plasmalemmal dopamine and vesicular monoamine transporters in methamphetamine‐induced dopaminergic deficits

G. Hanson, T. J. Volz, A. Fleckenstein, 2007, Journal of neurochemistry.

Methamphetamine‐Induced Rapid and Reversible Reduction in the Activities of Tryptophan Hydroxylase and Dopamine Transporters: Oxidative Consequences? a

R. Metzger, G. Hanson, J. Gibb, 1998, Annals of the New York Academy of Sciences.

3,4-Methylenedioxypyrovalerone: Neuropharmacological Impact of a Designer Stimulant of Abuse on Monoamine Transporters

G. Hanson, D. Wilkins, A. Fleckenstein, 2020, The Journal of Pharmacology and Experimental Therapeutics.

Ceramide-induced alterations in dopamine transporter function.

M. Topham, G. Hanson, A. Fleckenstein, 2003, European journal of pharmacology.

Pramipexole increases vesicular dopamine uptake: implications for treatment of Parkinson's neurodegeneration.

G. Hanson, A. Fleckenstein, Kristi S. Rau, 2003, European journal of pharmacology.

Differential role of histamine in mediating stress-induced changes in central dopaminergic neuronal activity in the rat

K. E. Moore, K. Lookingland, K. Moore, 1994, Brain Research.

Highly potent cocaine analogs cause long-lasting increases in locomotor activity.

M. Kuhar, F. Carroll, T. Kopajtic, 1996, European journal of pharmacology.

Therapeutic doses of amphetamine and methylphenidate selectively redistribute the vesicular monoamine transporter-2.

G. Hanson, A. Fleckenstein, E. Riddle, 2007, European journal of pharmacology.

Differential trafficking of the vesicular monoamine transporter-2 by methamphetamine and cocaine.

J. Haycock, M. Topham, G. Hanson, 2002, European journal of pharmacology.

Histaminergic neurons mediate restraint stress-induced increases in the activity of noradrenergic neurons projecting to the hypothalamus

K. Lookingland, K. Moore, A. Fleckenstein, 1994, Brain Research.

Effects of histamine on 5-hydroxytryptaminergic neuronal activity in the rat hypothalamus.

K. E. Moore, K. Lookingland, K. Moore, 1994, European journal of pharmacology.

Activation of noradrenergic neurons projecting to the diencephalon following central administration of histamine is mediated by H1 receptors

K. E. Moore, K. Lookingland, K. Moore, 1994, Brain Research.

Differential effects of histamine on the activity of hypothalamic dopaminergic neurons in the rat.

K. Lookingland, K. Moore, A. Fleckenstein, 1994, The Journal of pharmacology and experimental therapeutics.

Histaminergic neurons mediate restraint stress-induced activation of central 5-hydroxytryptaminergic neurons in the rat.

K. E. Moore, K. Lookingland, K. Moore, 1994, European journal of pharmacology.

Evidence that histamine-stimulated prolactin secretion is not mediated by an inhibition of tuberoinfundibular dopaminergic neurons.

K. Lookingland, K. Moore, A. Fleckenstein, 1992, Life sciences.

EFFECTS OF METHAMPHETAMINE ON STRIATAL NEUROPEPTIDE Y FUNCTION

K. Keefe, G. Hanson, A. Fleckenstein, 2012 .

Age-Dependent Methamphetamine-Induced Alterations in Vesicular Monoamine Transporter-2 Function: Implications for Neurotoxicity

K. Johnson-Davis, D. Crouch, G. Hanson, 2005, Journal of Pharmacology and Experimental Therapeutics.

Methamphetamine treatment rapidly inhibits serotonin, but not glutamate, transporters in rat brain

R. Metzger, G. Hanson, J. Gibb, 1998, Brain Research.

Methcathinone decreases dopamine transporter function: Role of protein kinase C

G. Hanson, D. Wilkins, A. Fleckenstein, 2021, Journal of neurochemistry.

Activation of mesolimbic dopaminergic neurons following central administration of histamine is mediated by H1 receptors

K. E. Moore, K. Lookingland, K. Moore, 2004, Naunyn-Schmiedeberg's Archives of Pharmacology.

Oxygen radicals differentially affect Na+/Cl(-)-dependent transporters.

H. Haughey, G. Hanson, A. Fleckenstein, 1999, European journal of pharmacology.

Measurement of kinetically resolved vesicular dopamine uptake and efflux using rotating disk electrode voltammetry

G. Hanson, T. J. Volz, A. Fleckenstein, 2006, Journal of Neuroscience Methods.

Evidence that prolactin mediates the stimulatory effects of estrogen on tuberoinfundibular dopamine neurons in female rats.

K. Lookingland, K. Moore, A. Fleckenstein, 1992, Neuroendocrinology.

Methamphetamine-induced decrease in tryptophan hydroxylase activity: role of 5-hydroxytryptaminergic transporters.

G. Hanson, J. Gibb, D. Wilkins, 1997, European journal of pharmacology.

Methamphetamine Administration Reduces Hippocampal Vesicular Monoamine Transporter-2 Uptake

G. Hanson, J. Gibb, T. J. Volz, 2006, Journal of Pharmacology and Experimental Therapeutics.

3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function.

R. Metzger, G. Hanson, J. Gibb, 1998, European journal of pharmacology.

4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of Abuse

G. Hanson, J. Gibb, D. Andrenyak, 2011, Journal of Pharmacology and Experimental Therapeutics.

The methamphetamine experience: a NIDA partnership

G. Hanson, A. Fleckenstein, Kristi S. Rau, 2004, Neuropharmacology.

Methamphetamine/amphetamine abuse and risk of Parkinson's disease in Utah: a population-based assessment.

Ken R Smith, Karen Curtin, Ken R. Smith, 2015, Drug and alcohol dependence.

New insights into the mechanism of action of amphetamines.

G. Hanson, J. Gibb, T. J. Volz, 2007, Annual review of pharmacology and toxicology.

Age‐dependent differences in dopamine transporter and vesicular monoamine transporter‐2 function and their implications for methamphetamine neurotoxicity

G. Hanson, T. J. Volz, A. Fleckenstein, 2008, Synapse.

Methylphenidate Administration Alters Vesicular Monoamine Transporter-2 Function in Cytoplasmic and Membrane-Associated Vesicles

G. Hanson, J. L. King, T. J. Volz, 2007, Journal of Pharmacology and Experimental Therapeutics.

Kinetic analysis of developmental changes in vesicular monoamine transporter‐2 function

G. Hanson, T. J. Volz, A. Fleckenstein, 2006, Synapse.

Amphetamine and methamphetamine reduce striatal dopamine transporter function without concurrent dopamine transporter relocalization

G. Hanson, A. Fleckenstein, Christopher L. German, 2012, Journal of neurochemistry.

Measurement of plasmalemmal dopamine transport, vesicular dopamine transport, and K+-stimulated dopamine release in frozen rat brain tissue

G. Hanson, T. J. Volz, A. Fleckenstein, 2009, Journal of Neuroscience Methods.

Methylphenidate Alters Vesicular Monoamine Transport and Prevents Methamphetamine-Induced Dopaminergic Deficits

G. Hanson, A. Fleckenstein, E. Riddle, 2003, Journal of Pharmacology and Experimental Therapeutics.

Age‐Dependent Differential Responses of Monoaminergic Systems to High Doses of Methamphetamine

G. Hanson, D. Wilkins, A. Fleckenstein, 2000, Journal of neurochemistry.

Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease

G. Hanson, A. Fleckenstein, L. McFadden, 2015, Pharmacological Reviews.

Methamphetamine-Induced Dopamine Transporter Complex Formation and Dopaminergic Deficits: The Role of D2 Receptor Activation

G. Hanson, Pei-Wen Chu, A. Fleckenstein, 2010, Journal of Pharmacology and Experimental Therapeutics.

Mechanisms Underlying Methamphetamine-Induced Dopamine Transporter Complex Formation

G. Hanson, J. Gibb, J. L. King, 2009, Journal of Pharmacology and Experimental Therapeutics.

Differential regional effects of methamphetamine on dopamine transport.

G. Hanson, Cameron S. Metcalf, Pei-Wen Chu, 2008, European journal of pharmacology.

Prior methamphetamine self-administration attenuates the dopaminergic deficits caused by a subsequent methamphetamine exposure

G. Hanson, Paula L. Vieira-Brock, A. Fleckenstein, 2015, Neuropharmacology.

Prior methamphetamine self-administration attenuates serotonergic deficits induced by subsequent high-dose methamphetamine administrations.

G. Hanson, Paula L. Vieira-Brock, Shannon M. Nielsen, 2012, Drug and alcohol dependence.

Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure

G. Hanson, D. Andrenyak, K. Stout, 2012, Journal of Pharmacology and Experimental Therapeutics.

Persistence of tolerance to methamphetamine-induced monoamine deficits.

K. Johnson-Davis, J. Danaceau, D. Wilkins, 2007, European journal of pharmacology.

The role of hyperthermia and metabolism as mechanisms of tolerance to methamphetamine neurotoxicity.

K. Johnson-Davis, D. Wilkins, A. Fleckenstein, 2003, European journal of pharmacology.

Tolerance to the neurotoxic effects of methamphetamine in young rats.

G. Hanson, D. Wilkins, A. Fleckenstein, 2002, European journal of pharmacology.

Interaction between hyperthermia and oxygen radical formation in the 5-hydroxytryptaminergic response to a single methamphetamine administration.

G. Hanson, J. Gibb, D. Wilkins, 1997, The Journal of pharmacology and experimental therapeutics.

Role of endogenous dopamine in the neurochemical deficits induced by methcathinone.

M. Gygi, G. Hanson, J. Gibb, 1997, The Journal of pharmacology and experimental therapeutics.

Sex differences in neurotensin and substance P following nicotine self‐administration in rats

R. Bevins, G. Hanson, S. Pittenger, 2016, Synapse.

The Effects of Methamphetamine on Serotonin Transporter Activity

H. Haughey, R. Metzger, G. Hanson, 2000, Journal of neurochemistry.

Methamphetamine self-administration attenuates hippocampal serotonergic deficits: role of brain-derived neurotrophic factor.

G. Hanson, Paula L. Vieira-Brock, A. Fleckenstein, 2014, The international journal of neuropsychopharmacology.

Differential effects of psychostimulants and related agents on dopaminergic and serotonergic transporter function.

H. Haughey, R. Metzger, G. Hanson, 1999, European journal of pharmacology.

Mechanisms of methamphetamine-induced dopaminergic neurotoxicity

G. Hanson, A. Fleckenstein, E. Riddle, 2006, The AAPS Journal.

Methamphetamine-induced alterations in monoamine transport: implications for neurotoxicity, neuroprotection and treatment.

G. Hanson, T. J. Volz, A. Fleckenstein, 2007, Addiction.

Cocaine Alters Vesicular Dopamine Sequestration and Potassium-Stimulated Dopamine Release: The Role of D2 Receptor Activation

G. Hanson, T. J. Volz, A. Fleckenstein, 2009, Journal of Pharmacology and Experimental Therapeutics.

A rapid and reversible change in dopamine transporters induced by methamphetamine.

R. Metzger, G. Hanson, J. Gibb, 1997, European journal of pharmacology.

Prior nicotine self-administration attenuates subsequent dopaminergic deficits of methamphetamine in rats: role of nicotinic acetylcholine receptors

J. McIntosh, G. Hanson, Shannon M. Nielsen, 2016, Behavioural pharmacology.

Methylphenidate-Induced Increases in Vesicular Dopamine Sequestration and Dopamine Release in the Striatum: The Role of Muscarinic and Dopamine D2 Receptors

G. Hanson, T. J. Volz, A. Fleckenstein, 2008, Journal of Pharmacology and Experimental Therapeutics.

Methamphetamine decreases mouse striatal dopamine transporter activity: roles of hyperthermia and dopamine.

G. Hanson, A. Fleckenstein, V. Sandoval, 2000, European journal of pharmacology.

Effect of Methamphetamine Self-Administration on Neurotensin Systems of the Basal Ganglia

P. S. Frankel, G. Hanson, M. Alburges, 2011, Journal of Pharmacology and Experimental Therapeutics.

Age‐Dependent Effects of Methamphetamine on VMAT‐2

G. Hanson, D. Wilkins, A. Fleckenstein, 2006, Annals of the New York Academy of Sciences.

Phencyclidine increases vesicular dopamine uptake.

G. Hanson, A. Fleckenstein, J. Hanson, 2002, European journal of pharmacology.

Brain Slice Staining and Preparation for Three-Dimensional Super-Resolution Microscopy.

E. Jorgensen, M. Gudheti, A. Fleckenstein, 2017, Methods in molecular biology.

Prior methylphenidate self-administration alters the subsequent reinforcing effects of methamphetamine in rats

G. Hanson, Shannon M. Nielsen, A. Fleckenstein, 2014, Behavioural pharmacology.

Methylphenidate Redistributes Vesicular Monoamine Transporter-2: Role of Dopamine Receptors

G. Hanson, A. Fleckenstein, E. Riddle, 2002, The Journal of Neuroscience.

Nature of methamphetamine-induced rapid and reversible changes in dopamine transporters.

R. Vaughan, G. Hanson, A. Fleckenstein, 1998, European journal of pharmacology.

D. Andrenyak, D. Wilkins, Paula L. Vieira-Brock, 2013, Nicotine & tobacco research : official journal of the Society for Research on Nicotine and Tobacco.

Psychostimulant-induced alterations in vesicular monoamine transporter-2 function: Neurotoxic and therapeutic implications

G. Hanson, T. J. Volz, A. Fleckenstein, 2009, Neuropharmacology.

Dopamine D(3) receptors contribute to methamphetamine-induced alterations in dopaminergic neuronal function: role of hyperthermia.

G. Hanson, A. Newman, Shannon M. Nielsen, 2014, European journal of pharmacology.

Mephedrone alters basal ganglia and limbic dynorphin systems

G. Hanson, M. Alburges, A. Fleckenstein, 2014, Synapse.

D2 Receptor-Mediated Regulation of Vesicular Dopamine Uptake

G. Hanson, J. Gibb, A. Fleckenstein, 2002 .

Methylenedioxymethamphetamine decreases plasmalemmal and vesicular dopamine transport: mechanisms and implications for neurotoxicity.

G. Hanson, J. Gibb, A. Fleckenstein, 2002, The Journal of pharmacology and experimental therapeutics.

Methamphetamine-induced dopaminergic deficits and refractoriness to subsequent treatment.

K. Keefe, G. Hanson, J. Gibb, 2009, European journal of pharmacology.

Nicotine Administration Attenuates Methamphetamine-Induced Novel Object Recognition Deficits

G. Hanson, Paula L. Vieira-Brock, Shannon M. Nielsen, 2015, The international journal of neuropsychopharmacology.

Drugs and society.

G. Hanson, A. Fleckenstein, Peter J. Venturelli, 1971, Lancet.

Methamphetamine-induced rapid and reversible reduction in the activities of tryptophan hydroxylase and dopamine transporters: oxidative consequences?

R. Metzger, G. Hanson, J. Gibb, 1998, Annals of the New York Academy of Sciences.

Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride].

M. Kuhar, F. Carroll, A. Fleckenstein, 1996, The Journal of pharmacology and experimental therapeutics.

Increased risk of diseases of the basal ganglia and cerebellum in patients with a history of attention-deficit/hyperactivity disorder

Ken R. Smith, P. Renshaw, D. Yurgelun-Todd, 2018, Neuropsychopharmacology.

Iptakalim attenuates self-administration and acquired goal-tracking behavior controlled by nicotine

R. Bevins, Ming Li, K. Fink, 2013, Neuropharmacology.

Alterations in Vesicular Dopamine Uptake Contribute to Tolerance to the Neurotoxic Effects of Methamphetamine

K. Johnson-Davis, D. Wilkins, A. Fleckenstein, 2004, Journal of Pharmacology and Experimental Therapeutics.

Bupropion increases striatal vesicular monoamine transport

K. Johnson-Davis, F. Carroll, G. Hanson, 2005, Neuropharmacology.

An acute, epitope‐specific modification in the dopamine transporter associated with methamphetamine‐induced neurotoxicity

Danielle M. Friend, K. Keefe, G. Hanson, 2016, Synapse.

The effects of methamphetamine self‐administration on cortical monoaminergic deficits induced by subsequent high‐dose methamphetamine administrations

G. Hanson, A. Fleckenstein, L. McFadden, 2013, Synapse.

Methamphetamine treatment during development attenuates the dopaminergic deficits caused by subsequent high‐dose methamphetamine administration

G. Hanson, J. Gibb, K. Stout, 2010, Synapse.

Psychostimulants and Vesicle Trafficking: A Novel Mechanism and Therapeutic Implications

G. Hanson, Glen R Hanson, Annette E Fleckenstein, 2004, Annals of the New York Academy of Sciences.

Chronic Nicotine Exposure Attenuates Methamphetamine-Induced Dopaminergic Deficits

J. McIntosh, G. Hanson, K. Stout, 2015, The Journal of Pharmacology and Experimental Therapeutics.

Methylphenidate alters basal ganglia neurotensin systems through dopaminergic mechanisms: a comparison with cocaine treatment

G. Hanson, M. Alburges, A. Fleckenstein, 2011, Journal of neurochemistry.

Comparison of the efficacy of mechanistically different antioxidants in the rat hemorrhagic shock model.

E. Hall, S. L. Smith, A. Fleckenstein, 1991, Circulatory shock.

Methamphetamine Self-Administration Causes Persistent Striatal Dopaminergic Alterations and Mitigates the Deficits Caused by a Subsequent Methamphetamine Exposure

G. Hanson, D. Andrenyak, D. Wilkins, 2012, Journal of Pharmacology and Experimental Therapeutics.

Effect of methamphetamine on tryptophan hydroxylase activity: role of hyperthermia.

A. Fleckenstein, 1997, European Journal of Pharmacology.

Method development and validation of an in vitro model of the effects of methylphenidate on membrane-associated synaptic vesicles

G. Hanson, T. J. Volz, A. Fleckenstein, 2009, Journal of Neuroscience Methods.

Mephedrone alters basal ganglia and limbic dynorphin systems

G. Hanson, M. Alburges, A. Fleckenstein, 2014, Synapse.

Dopamine D2 receptor activation increases vesicular dopamine uptake and redistributes vesicular monoamine transporter-2 protein.

A. Newman, G. Hanson, A. Fleckenstein, 2004, European journal of pharmacology.

Ephedrine decreases vesicular monoamine transporter‐2 function

G. Hanson, A. Fleckenstein, Christopher L. German, 2011, Synapse.

Bath salts and synthetic cathinones: an emerging designer drug phenomenon.

G. Hanson, A. Fleckenstein, Christopher L. German, 2014, Life sciences.